Releases

News

Releases

18. November, 2022

Third quarter report Q3-2022

Cessatech today releases its results for the period 1 July – 30 September 2022....

Read more

Releases

14. November, 2022

Successful outcome of Rights issue

The results of the rights issue announced on October 19, 2022 for which the...

Read more

Releases

19. October, 2022

DKK 18.3 million capital raise through a 80% guarantee

DKK 18.3 MILLION CAPITAL RAISE THROUGH A 80% GUARANTEED RIGHTS ISSUE TO FINANCE PIVOTAL...

Read more

Releases

23. September, 2022

Successful outcome of pharmacokinetic trial in children of lead candidate

Cessatech A/S announces positive topline outcome of its Phase 2 pharmacokinetics trial with CT001...

Read more

Releases

5. September, 2022

First patient dosed in pivotal trial of lead product candidate

First patient has been dosed in pivotal trial of lead candidate CT001 The pivotal...

Read more

Releases

19. August, 2022

Second quarter report Q2-2022

Cessatech A/S today releases its results for the period 1 April – 30 June...

Read more

Media

9. August, 2022

Donated the prize money to Rigshospitalet – Toy’s for the Children

We donated the prize money we won from the Rotary entrepreneurship award to Rigshospital...

Read more

Releases

30. June, 2022

Regulatory Green Light for trial 0205, the pivotal trial for CT001 – first patient expected shortly

Cessatech A/S announces that the pivotal trial 0205 has obtained regulatory approval and thereby...

Read more

Releases

16. May, 2022

Cessatech reports last patient dosed in pharmacokinetic trial in children of lead candidate

Clinical trial 0206 will investigate the pharmacokinetics of CT001 in children aged 1-17 undergoing...

Read more

Releases

19. April, 2022

First quarter report Q1-2022

Cessatech A/S today releases its results for the period 1 January – 31 March...

Read more

Media

5. April, 2022

Altinget: mindre u-hyg-ge-ligt…

  “Hospitalophold- og behandling kan være en hård omgang for børn. Med den smertestillende...

Read more

Facts

15. March, 2022

Off-label use of medication in children continue to be the rule rather than the exception…

A systematic review of 31 studies with off-label prescription rates confirms the continued off-label...

Read more

Stay up to date!

Subscribe and get notified on Cessatech's latest news.